{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:10:53Z","timestamp":1780643453894,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1124\/jpet.108.141333","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:34:45Z","timestamp":1221096885000},"page":"665-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Niacin-induced \u201cFlush\u201d Involves Release of Prostaglandin D2 from Mast Cells and Serotonin from Platelets: Evidence from Human Cells in Vitro and an Animal Model"],"prefix":"10.1016","volume":"327","author":[{"given":"Dean","family":"Papaliodis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duraisamy","family":"Kempuraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Michaelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adams","family":"Wolfberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoharis C.","family":"Theoharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.141333_bib1","doi-asserted-by":"crossref","unstructured":"Askenase PW, Bursztajn S, Gershon MD, and Gershon RK (1980) T-cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med 152: 1358-1374.","DOI":"10.1084\/jem.152.5.1358"},{"key":"10.1124\/jpet.108.141333_bib2","doi-asserted-by":"crossref","unstructured":"Bellows CF, Alder A, Wludyka P, and Jaffe BM (2006) Modulation of macrophage nitric oxide production by prostaglandin D(2). J Surg Res 132: 92-97.","DOI":"10.1016\/j.jss.2005.08.017"},{"key":"10.1124\/jpet.108.141333_bib3","doi-asserted-by":"crossref","unstructured":"Beny\u00f3 Z, Gille A, Bennett CL, Clausen BE, and Offermanns S (2006) Nicotinic acid-induced flushings is mediated by activation of epidermal Langerhans cells. Mol Pharmacol 70: 1844-1899.","DOI":"10.1124\/mol.106.030833"},{"key":"10.1124\/jpet.108.141333_bib4","doi-asserted-by":"crossref","unstructured":"Beny\u00f3 Z, Gille A, Kero J, Csiky M, Such\u00e1nkov\u00e1 MC, Nusing RM, Moers A, Pfeffer K, and Offermanns S (2005) GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 115: 3634-3640.","DOI":"10.1172\/JCI23626"},{"key":"10.1124\/jpet.108.141333_bib5","doi-asserted-by":"crossref","unstructured":"Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345: 1583-1592.","DOI":"10.1056\/NEJMoa011090"},{"key":"10.1124\/jpet.108.141333_bib6","doi-asserted-by":"crossref","unstructured":"Carlson LA (2005) Nicotinic acid: the broad-spectrum lipid drug: a 50th anniversary review. J Intern Med 258: 94-114.","DOI":"10.1111\/j.1365-2796.2005.01528.x"},{"key":"10.1124\/jpet.108.141333_bib7","doi-asserted-by":"crossref","unstructured":"Cefali EA, Simmons PD, Stanek EJ, McGovern ME, and Kissling CJ (2007) Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation. Int J Clin Pharmacol Ther 45: 78-88.","DOI":"10.5414\/CPP45078"},{"key":"10.1124\/jpet.108.141333_bib8","doi-asserted-by":"crossref","unstructured":"Cefali EA, Simmons PD, Stanek EJ, and Shamp TR (2006) Improved control of niacin-induced flushing using an optimized once-daily, extended niacin formulation. Int J Clin Pharmacol Ther 44: 633-640.","DOI":"10.5414\/CPP44633"},{"key":"10.1124\/jpet.108.141333_bib9","doi-asserted-by":"crossref","unstructured":"Cheng K, Wu TJ, Wu KK, Sturino C, Metters K, Gottesdiener K, Wright SD, Wang Z, O\u2019Neill G, Lai E, et al. (2006) Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A 103: 6682-6687.","DOI":"10.1073\/pnas.0601574103"},{"key":"10.1124\/jpet.108.141333_bib10","doi-asserted-by":"crossref","unstructured":"Cosi C and Koek W (2001) Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells. Eur J Pharmacol 433: 55-62.","DOI":"10.1016\/S0014-2999(01)01493-5"},{"key":"10.1124\/jpet.108.141333_bib11","doi-asserted-by":"crossref","unstructured":"D\u2019Souza Y, Fombonne E, and Ward BJ (2006) No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118: 1664-1675.","DOI":"10.1542\/peds.2006-1262"},{"key":"10.1124\/jpet.108.141333_bib12","doi-asserted-by":"crossref","unstructured":"Dunn RT, Ford MA, Rindone JP, and Kwiecinski FA (1995) Low-dose aspirin and ibuprofen reduce the cutaneous reactions following niacin administration. Am J Ther 2: 478-480.","DOI":"10.1097\/00045391-199506000-00006"},{"key":"10.1124\/jpet.108.141333_bib13","doi-asserted-by":"crossref","unstructured":"Gupta EK and Ito MK (2002) Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia. Heart Dis 4: 124-137.","DOI":"10.1097\/00132580-200203000-00010"},{"key":"10.1124\/jpet.108.141333_bib14","doi-asserted-by":"crossref","unstructured":"Guyton JR, Goldberg AC, Kreisberg RA, Sprecher DL, Superko HR, and O\u2019Connor CM (1998) Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol 82: 737-743.","DOI":"10.1016\/S0002-9149(98)00448-2"},{"key":"10.1124\/jpet.108.141333_bib15","doi-asserted-by":"crossref","unstructured":"Jungnickel PW, Maloley PA, Vander Tuin EL, Peddicord TE, and Campbell JR (1997) Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions. J Gen Intern Med 12: 591-596.","DOI":"10.1046\/j.1525-1497.1997.07118.x"},{"key":"10.1124\/jpet.108.141333_bib16","doi-asserted-by":"crossref","unstructured":"Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, Cetrulo CL, and Theoharides TC (2005) Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 145: 934-944.","DOI":"10.1038\/sj.bjp.0706246"},{"key":"10.1124\/jpet.108.141333_bib17","doi-asserted-by":"crossref","unstructured":"Kempuraj D, Saito H, Kaneko A, Fukagawa K, Nakayama M, Toru H, Tomikawa M, Tachimoto H, Ebisawa M, Akasawa A, et al. (1999) Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93: 3338-3346.","DOI":"10.1182\/blood.V93.10.3338.410k05_3338_3346"},{"key":"10.1124\/jpet.108.141333_bib18","doi-asserted-by":"crossref","unstructured":"Knowles HJ, te Poele RH, Workman P, and Harris AL (2006) Niacin induces PPAR-gamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol 71: 646-656.","DOI":"10.1016\/j.bcp.2005.11.019"},{"key":"10.1124\/jpet.108.141333_bib19","doi-asserted-by":"crossref","unstructured":"Kushnir-Sukhov NM, Brown JM, Wu Y, Kirshenbaum A, and Metcalfe DD (2007) Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol 119: 498-499.","DOI":"10.1016\/j.jaci.2006.09.003"},{"key":"10.1124\/jpet.108.141333_bib20","doi-asserted-by":"crossref","unstructured":"Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, Michiels N, Vets E, O\u2019Neill G, Wagner JA, and Gottesdiener K (2007) Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D(2) receptor subtype 1. Clin Pharmacol Ther 81: 849-857.","DOI":"10.1038\/sj.clpt.6100180"},{"key":"10.1124\/jpet.108.141333_bib21","doi-asserted-by":"crossref","unstructured":"Libby P (2005) The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol 46: 1225-1228.","DOI":"10.1016\/j.jacc.2005.07.006"},{"key":"10.1124\/jpet.108.141333_bib22","doi-asserted-by":"crossref","unstructured":"Loong SC, Lance JW, and Rawle KC (1968) The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105. Med J Aust 2: 845-848.","DOI":"10.5694\/j.1326-5377.1968.tb83235.x"},{"key":"10.1124\/jpet.108.141333_bib23","doi-asserted-by":"crossref","unstructured":"Lorenzen A, Stannek C, Burmeister A, Kalvinsh I, and Schwabe U (2002) G protein-coupled receptor for nicotinic acid in mouse macrophages. Biochem Pharmacol 64: 645-648.","DOI":"10.1016\/S0006-2952(02)01220-0"},{"key":"10.1124\/jpet.108.141333_bib24","doi-asserted-by":"crossref","unstructured":"Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidatov I, Behan DP, and Connolly DT (2006) Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 126: 2637-2646.","DOI":"10.1038\/sj.jid.5700586"},{"key":"10.1124\/jpet.108.141333_bib25","doi-asserted-by":"crossref","unstructured":"Matuchansky C and Launay JM (1995) Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites. Gastroenterology 108: 743-751.","DOI":"10.1016\/0016-5085(95)90447-6"},{"key":"10.1124\/jpet.108.141333_bib26","doi-asserted-by":"crossref","unstructured":"McCormack PL and Keating GM (2005) Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs 65: 2719-2740.","DOI":"10.2165\/00003495-200565180-00014"},{"key":"10.1124\/jpet.108.141333_bib27","doi-asserted-by":"crossref","unstructured":"McKenney J (2004) New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 164: 697-705.","DOI":"10.1001\/archinte.164.7.697"},{"key":"10.1124\/jpet.108.141333_bib28","doi-asserted-by":"crossref","unstructured":"Meyers CD, Liu P, Kamanna VS, and Kashyap ML (2007) Nicotinic acid induces secretion of prostaglandin D(2) in human macrophages: An in vitro model of the niacin flush. Atherosclerosis 192: 253-258.","DOI":"10.1016\/j.atherosclerosis.2006.07.014"},{"key":"10.1124\/jpet.108.141333_bib29","doi-asserted-by":"crossref","unstructured":"Morgan JM, Capuzzi DM, and Guyton JR (1998) A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol 82: 29U-34U.","DOI":"10.1016\/S0002-9149(98)00732-2"},{"key":"10.1124\/jpet.108.141333_bib30","doi-asserted-by":"crossref","unstructured":"Morrow JD, Awad JA, Oates JA, and Roberts LJ (1992) Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 98: 812-815.","DOI":"10.1111\/1523-1747.ep12499963"},{"key":"10.1124\/jpet.108.141333_bib31","doi-asserted-by":"crossref","unstructured":"Morrow JD, Parsons WG 3rd, and Roberts LJ 2nd (1989) Release of markedly increased quantities of prostaglandin D2 in vivo in humans following administration of nicotinic acid. Prostaglandins 38: 263-274.","DOI":"10.1016\/0090-6980(89)90088-9"},{"key":"10.1124\/jpet.108.141333_bib32","doi-asserted-by":"crossref","unstructured":"Papaliodis D, Boucher W, Kempuraj D, and Theoharides TC (2008) The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol 153: 1382-1387.","DOI":"10.1038\/sj.bjp.0707668"},{"key":"10.1124\/jpet.108.141333_bib33","doi-asserted-by":"crossref","unstructured":"Plank J and Feldman JM (1975) Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine. Metabolism 24: 1035-1046.","DOI":"10.1016\/0026-0495(75)90097-9"},{"key":"10.1124\/jpet.108.141333_bib34","doi-asserted-by":"crossref","unstructured":"Rosenow EC 3rd (2005) Patients\u2019 understanding of and compliance with medications: the sixth vital sign? Mayo Clin Proc 80: 983-987.","DOI":"10.4065\/80.8.983"},{"key":"10.1124\/jpet.108.141333_bib35","unstructured":"Saeed SA, Rasheed H, and Gilani AU (2003) Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways. Acta Pharmacol Sin 24: 958-964."},{"key":"10.1124\/jpet.108.141333_bib36","doi-asserted-by":"crossref","unstructured":"Soudijin W, van Wijngssrden I, and Ijzerman AP (2007) Nicotinic acid receptor subtypes and their ligands. Med Res Rev 27: 417-433.","DOI":"10.1002\/med.20102"},{"key":"10.1124\/jpet.108.141333_bib37","doi-asserted-by":"crossref","unstructured":"Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, and Chrousos G (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139: 403-413.","DOI":"10.1210\/endo.139.1.5660"},{"key":"10.1124\/jpet.108.141333_bib38","doi-asserted-by":"crossref","unstructured":"Turenne SD, Seeman M, and Ross BM (2001) An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response. Schizophr Res 50: 191-197.","DOI":"10.1016\/S0920-9964(00)00082-7"},{"key":"10.1124\/jpet.108.141333_bib39","doi-asserted-by":"crossref","unstructured":"Urade Y, Urihara M, Horiguchi Y, Ikai K, and Hayaishi O (1989) The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells: localization of glutathione-requiring PGD2 synthetase in histiocytes, dendritic and Kupffer cells in various rat tissues. J Immunol 143: 2982-2989.","DOI":"10.4049\/jimmunol.143.9.2982"},{"key":"10.1124\/jpet.108.141333_bib40","doi-asserted-by":"crossref","unstructured":"Utsunomiya T, Krausz MM, Shepro D, and Hechtman HB (1981) Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals. Am J Physiol 241: H766-H771.","DOI":"10.1152\/ajpheart.1981.241.5.H766"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524346919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524346919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.141333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:47:12Z","timestamp":1740005232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524346919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0022356524346919"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.141333","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niacin-induced \u201cFlush\u201d Involves Release of Prostaglandin D2 from Mast Cells and Serotonin from Platelets: Evidence from Human Cells in Vitro and an Animal Model","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.141333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}